you are here: Home News Cdsco

Cdsco

Cough syrup deaths: Old regulatory failures resurface as CDSCO calls for ‘strict quality control’
Not in the bin, down the drain: Why India’s drug regulator wants you to flush these 17 expired medicines immediately
Wockhardt shares rally 5% after Indian drug regulator approves Pneumonia antibiotic
111 drug samples tested in November found 'not of standard quality'
Non-genuine, spurious: Torrent Pharma's Shelcal 500 that failed CDSCO test not made by company
Sanofi gets CDSCO nod for Beyfortus India
Drugs controller orders immediate withdrawal of unapproved anti-bacterial drug
What are nutraceuticals and why is government planning more regulations around them?
CDSCO inspections highlight major problems in pharmaceutical units and testing labs
Samples of 59 drugs declared as 'not of standard quality': CDSCO
Regulator begins major enforcement drive on poor drug-making practices
How Sun Pharma’s complaint helped authorities seize fake medicines worth Rs 2 cr
AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer
Cystic fibrosis patients pitch for life-saving drugs that are currently unavailable in India
Is uniform implementation of drug approval system a possibility in India?
Merge state, central drug regulators for better standards: Bharat Biotech chairman
"Ill-informed and erroneous': Govt refutes reports claiming admission of COVID vaccine side-effects
What can the inspection of select drugmaking units hope to achieve?
Exclusive | Uzbekistan Cough Syrup Case: Drugs sold by Marion Biotech in India under scanner
Uzbekistan claims cough syrup made in Noida responsible for death of 18 kids; CDSCO calls for causality assessment report
Will pose an initial challenge, but a well-thought-out move, drug makers say of mandatory QR codes on branded medicines
Health ministry trashes reports of hasty approval to Covaxin under political pressure
Newer, advanced drugs rapidly changing breast cancer treatment outcomes, patient experience: Experts
How Maiden and other Indian pharma firms exploited WHO certification process
Why Indian regulators fail to prevent fatal lapses in drug manufacturing

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Cdsco

Cough syrup deaths: Old regulatory failures resurface as CDSCO calls for ‘strict quality control’

Not in the bin, down the drain: Why India’s drug regulator wants you to flush these 17 expired medicines immediately

Wockhardt shares rally 5% after Indian drug regulator approves Pneumonia antibiotic

111 drug samples tested in November found 'not of standard quality'

Non-genuine, spurious: Torrent Pharma's Shelcal 500 that failed CDSCO test not made by company

Sanofi gets CDSCO nod for Beyfortus India

Drugs controller orders immediate withdrawal of unapproved anti-bacterial drug

What are nutraceuticals and why is government planning more regulations around them?

CDSCO inspections highlight major problems in pharmaceutical units and testing labs

Samples of 59 drugs declared as 'not of standard quality': CDSCO

Regulator begins major enforcement drive on poor drug-making practices

How Sun Pharma’s complaint helped authorities seize fake medicines worth Rs 2 cr

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer

Cystic fibrosis patients pitch for life-saving drugs that are currently unavailable in India

Is uniform implementation of drug approval system a possibility in India?

Merge state, central drug regulators for better standards: Bharat Biotech chairman

"Ill-informed and erroneous': Govt refutes reports claiming admission of COVID vaccine side-effects

What can the inspection of select drugmaking units hope to achieve?

Exclusive | Uzbekistan Cough Syrup Case: Drugs sold by Marion Biotech in India under scanner

Uzbekistan claims cough syrup made in Noida responsible for death of 18 kids; CDSCO calls for causality assessment report

Will pose an initial challenge, but a well-thought-out move, drug makers say of mandatory QR codes on branded medicines

Health ministry trashes reports of hasty approval to Covaxin under political pressure

Newer, advanced drugs rapidly changing breast cancer treatment outcomes, patient experience: Experts

How Maiden and other Indian pharma firms exploited WHO certification process

Why Indian regulators fail to prevent fatal lapses in drug manufacturing